2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Multiple Myeloma: Should We Consider Idecabtagene Vicleucel, Anti-BCMA CAR-T Therapy, Effective in Heavily Pretreated R/R MM?

153 views
August 6, 2020
Comments 0
Login to view comments. Click here to Login